Shopping Cart
Remove All
Your shopping cart is currently empty
Magrolimab (Synonyms: Magrolimab (anti-CD47), Hu5F9-G4)
Catalog No. T35390 Copy Product Info
🥰Excellent
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Magrolimab
Copy Product Info🥰Excellent
Catalog No. T35390
Synonyms Magrolimab (anti-CD47), Hu5F9-G4
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Cas No. 2169232-81-7
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $163 | In Stock | In Stock | |
| 5 mg | $479 | In Stock | In Stock | |
| 10 mg | $745 | - | In Stock | |
| 25 mg | $1,120 | Inquiry | Inquiry | |
| 50 mg | $1,490 | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma. |
| Synonyms | Magrolimab (anti-CD47), Hu5F9-G4 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD47 Protein (His) at 2 μg/mL (30 μL/well) can bind Magrolimab. The EC50 is 0.007668 μg/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD47 |
| Molecular Weight | 145.74 kDa |
| Cas No. | 2169232-81-7 |
| Relative Density. | no data available |
| Isotype | Human IgG4SP kappa |
| Recommended Isotype Control |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Preview
Related Tags: buy Magrolimab | purchase Magrolimab | Magrolimab cost | order Magrolimab | Magrolimab chemical structure | Magrolimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.